Finance

Lists
Why is CUE down 4.73%?
Dive Deeper
CUE:NASDAQ
Cue Biopharma Inc
$24.36
-4.73%
(-1.21) 1D
Oct 5, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CUE...
Open
$25.60
High
$25.94
Low
$22.21
Mkt. cap
176.96M
Avg. vol.
348.49K
Volume
272.63K
52-wk high
$45.50
52-wk low
$4.97
EPS
-$26.99
Beta
2.62
Shares outstanding
7.26M
No. of employees
29
Open
$25.60
High
$25.94
Low
$22.21
Mkt. cap
176.96M
Avg. vol.
348.49K
Volume
272.63K
52-wk high
$45.50
52-wk low
$4.97
EPS
-$26.99
Beta
2.62
Shares outstanding
7.26M
No. of employees
29
News stories
From web sources and news partners
About Cue Biopharma Inc
CEO-
Employees29
Founded2014
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitecuebiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to CUE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CUE in the last 3 months
Highest
Current $24.36
$83.00 (+240.72%)
Average
$83.00 (+240.72%)
Lowest
$83.00 (+240.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Initiated
$83.00
+240.7%
09/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.15M
21.94M
5.69M
7.88M
Cost of goods sold
4.15M
15.93M
6.40M
48.51M
Cost of revenue
4.15M
15.93M
6.40M
48.51M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.54M
4.05M
4.65M
47.06M
Operating expense
5.54M
4.05M
4.65M
47.06M
Total operating expenses
9.69M
19.98M
11.05M
95.57M
Operating income
-7.54M
1.96M
-5.36M
-87.70M
Other non operating income
-
-
-
-65.52M
EBT including unusual items
-7.45M
2.08M
-5.18M
-153.07M
EBT excluding unusual items
-7.40M
2.06M
-5.19M
-153.07M
Income tax expense
-
500.00K
-
-
Effective tax rate
-
23.98%
-
-
Other operating expenses
-
-
-
-
Net income
-7.45M
1.58M
-5.18M
-153.07M
Net profit margin
-346.58%
7.22%
-91.07%
-1,943.21%
Earnings per share
-2.10
-
-
-
Interest and investment income
222.00K
158.00K
179.00K
157.00K
Interest expense
-75.00K
-51.00K
-4.00K
-5.00K
Net interest expenses
147.00K
107.00K
175.00K
152.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.46M
2.64M
-4.80M
-87.66M
Gain or loss from assets sale
51.00K
-20.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps